VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EYPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EYPTEyePoint Pharmaceuticals, Inc.
$14.02$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEYPTQuarterly Financials

EyePoint Pharmaceuticals, Inc. (EYPT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

EyePoint Pharmaceuticals, Inc. (EYPT) quarterly income statement — complete revenue, gross profit & net income history

EYPT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue696K620K966K5.33M24.45M11.59M10.52M9.48M11.68M14.03M15.2M9.11M7.68M10.53M10.01M11.56M9.29M11.54M9.06M9.01M
Revenue Growth %-97.15%-94.65%-90.82%-43.73%109.29%-17.39%-30.77%4.09%52.08%33.18%51.84%-21.27%-17.33%-8.76%10.52%28.31%26.92%61.88%-42.28%118.66%
Cost of Goods Sold528K375K721K165K805K816K736K1.4M759K998K1.2M1.79M640K3.41M1.41M1.73M1.78M3.03M1.82M1.93M
COGS % of Revenue75.86%60.48%74.64%3.09%3.29%7.04%6.99%14.78%6.5%7.11%7.91%19.68%8.33%32.37%14.03%14.99%19.12%26.27%20.15%21.4%
Gross Profit168K245K245K5.17M23.65M10.77M9.79M8.08M10.93M13.03M14M7.31M7.04M7.12M8.61M9.83M7.52M8.51M7.23M7.08M
Gross Margin %24.14%39.52%25.36%96.91%96.71%92.96%93.01%85.22%93.5%92.89%92.09%80.32%91.67%67.63%85.97%85.01%80.88%73.73%79.85%78.6%
Gross Profit Growth %-99.29%-97.73%-97.5%-36.01%116.46%-17.33%-30.09%10.43%55.12%82.93%62.66%-25.61%-6.31%-16.31%18.98%38.78%26.7%82.25%-47.63%95.69%
Operating Expenses87.39M70.59M62.27M67.39M72.48M56.01M42.54M42.62M44.25M29.38M28.4M30.07M28.6M50.86M27M29.05M25.8M26.56M22.55M18.06M
OpEx % of Revenue12556.61%11385.48%6446.17%1263.74%296.43%483.35%404.18%449.74%378.69%209.47%186.8%330.3%372.21%482.84%269.73%251.16%277.61%230.08%248.89%200.41%
Selling, General & Admin15.25M11.38M14.52M11.9M13.91M12.64M12.99M12.8M14.11M11.43M11.04M14.34M14.98M14.41M15.23M15.44M15.24M17.03M13.43M11.84M
SG&A % of Revenue2190.52%1834.84%1502.69%223.08%56.89%109.07%123.47%135.06%120.74%81.5%72.59%157.54%194.96%136.82%152.1%133.51%163.99%147.51%148.29%131.4%
Research & Development72.15M59.21M47.75M55.5M58.57M43.37M29.54M29.82M30.14M17.95M17.36M15.73M13.62M15.54M11.16M12.99M9.95M8.92M8.5M5.61M
R&D % of Revenue10366.09%9550.65%4943.48%1040.65%239.54%374.28%280.71%314.68%257.95%127.97%114.22%172.76%177.25%147.56%111.49%112.34%107%77.25%93.81%62.19%
Other Operating Expenses00000000000001000K615K615K615K615K615K615K
Operating Income-87.23M-70.34M-62.02M-62.23M-48.84M-45.24M-32.75M-34.55M-33.32M-16.35M-14.4M-22.76M-21.55M-43.73M-18.4M-19.22M-18.28M-18.05M-15.31M-10.98M
Operating Margin %-12532.47%-11345.97%-6420.81%-1166.83%-199.72%-390.4%-311.17%-364.52%-285.18%-116.58%-94.71%-249.98%-280.54%-415.22%-183.76%-166.16%-196.73%-156.36%-169.04%-121.81%
Operating Income Growth %-78.61%-55.5%-89.4%-80.13%-46.57%-176.62%-127.45%-51.78%-54.59%62.61%21.74%-18.45%-17.88%-142.3%-20.15%-75.02%-67.21%-41.71%-682.47%1.55%
EBITDA-87.23M-70.34M-61.45M-61.69M-48.34M-44.77M-32.34M-34.18M-33.02M-16.24M-14.28M-22.63M-21.45M-43.4M-17.69M-18.51M-17.59M-17.35M-14.7M-10.29M
EBITDA Margin %-12532.47%-11345.97%-6361.18%-1156.74%-197.69%-386.37%-307.3%-360.7%-282.59%-115.78%-93.95%-248.53%-279.17%-412.04%-176.66%-160.07%-189.24%-150.31%-162.25%-114.21%
EBITDA Growth %-80.44%-57.12%-90.01%-80.46%-46.41%-175.66%-126.42%-51.06%-53.94%62.58%19.25%-22.24%-21.95%-150.12%-20.34%-79.83%-71.62%-43.79%-1034.98%1.79%
D&A (Non-Cash Add-back)00576K538K497K467K408K362K303K112K115K132K105K335K711K704K696K698K615K685K
EBIT-87.23M-70.34M-59.73M-62.23M-48.84M-41.3M-29.36M-30.83M-29.28M-14.02M-12.61M-22.48M-20.35M-42.67M-17.76M-18.85M-19.78M-18.04M-15.31M-8.63M
Net Interest Income2.34M2.92M2.29M2.89M3.64M3.93M3.39M3.72M4.04M2.34M1.79M1.19M390K283K-22K-190K-1.13M-1.38M-1.38M-1.1M
Interest Income2.34M2.92M2.29M2.89M3.64M3.94M3.39M3.72M4.04M2.34M1.79M1.62M1.2M1.06M640K362K61K6K6K280K
Interest Expense0000014K00000435K812K781K662K552K1.19M1.39M1.39M1.38M
Other Income/Expense2.34M2.92M2.29M2.89M3.64M3.93M3.39M3.72M4.04M2.34M1.79M-159K390K283K-22K-190K-2.69M-1.38M-1.38M969K
Pretax Income-84.88M-67.42M-59.73M-59.33M-45.2M-41.31M-29.36M-30.83M-29.28M-14.02M-12.61M-22.92M-21.16M-43.45M-18.42M-19.41M-20.98M-19.43M-16.7M-10.01M
Pretax Margin %-12195.69%-10874.68%-6183.44%-1112.56%-184.82%-356.48%-278.99%-325.27%-250.63%-99.91%-82.96%-251.73%-275.47%-412.53%-183.98%-167.8%-225.69%-168.33%-184.29%-111.06%
Income Tax50K-186K093K090K00083K0000000000
Effective Tax Rate %-0.06%0.28%0%-0.16%0%-0.22%0%0%0%-0.59%0%0%0%0%0%0%0%0%0%0%
Net Income-84.83M-67.61M-59.73M-59.43M-45.2M-41.4M-29.36M-30.83M-29.28M-14.1M-12.61M-22.92M-21.16M-43.45M-18.42M-19.41M-20.98M-19.43M-16.7M-10.01M
Net Margin %-12188.51%-10904.68%-6183.44%-1114.31%-184.82%-357.26%-278.99%-325.27%-250.63%-100.51%-82.96%-251.73%-275.47%-412.53%-183.98%-167.8%-225.69%-168.33%-184.29%-111.06%
Net Income Growth %-87.7%-63.31%-103.44%-92.78%-54.33%-193.63%-132.8%-34.49%-38.37%67.55%31.53%-18.11%-0.9%-123.61%-10.33%-93.87%-70.81%-25.62%-339.23%22.7%
Net Income (Continuing)-84.93M-67.24M-59.73M-59.43M-45.2M-41.4M-29.36M-30.83M-29.28M-14.1M-12.61M-22.92M-21.16M-43.45M-18.42M-19.41M-20.98M-19.43M-16.7M-10.01M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.99-0.81-0.85-0.85-0.65-0.64-0.54-0.58-0.55-0.33-0.33-0.61-0.58-1.72-0.49-0.52-0.60-0.59-0.58-0.35
EPS Growth %-52.31%-26.56%-57.41%-46.55%-18.18%-93.94%-63.64%4.92%5.17%80.81%32.65%-17.31%3.33%-191.53%15.52%-48.57%-20%44.86%-93.33%66.35%
EPS (Basic)-0.99-0.81-0.85-0.85-0.65-0.64-0.54-0.58-0.55-0.33-0.33-0.61-0.58-1.72-0.49-0.52-0.60-0.59-0.58-0.35
Diluted Shares Outstanding86M83.03M70.17M69.93M69.77M64.56M54.45M53.21M52.91M42.17M38.34M37.58M37.49M37.35M37.34M37.32M37.25M32.7M28.77M28.74M
Basic Shares Outstanding86M83.03M70.17M69.93M69.77M64.56M54.45M53.21M52.91M42.17M38.34M37.58M37.49M37.35M37.34M37.32M37.25M32.7M28.77M28.6M
Dividend Payout Ratio--------------------